Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
doi: 10.1155/2021/9916328 206 LiHLiXLiMLiWWeiJHuangYet al
Rybelsus (semaglutide) is a prescription medication that is the first oral treatment of its kind for adults with type 2 diabetes
Other health factors
It can last 1 to 3 years
The safety and pharmacodynamic results in the multiple-dose trial must be interpreted in light of the high dose levels (2040 mg oral semaglutide) and the relatively fast initial dose escalation in this trial compared with the phase III trials, where dose levels of 314 mg oral semaglutide are investigated and a slower initial dose escalation is used to minimise gastrointestinal adverse effects
Importantly, both drugs produced clinically meaningful outcomes
